He said that the third stage of the trials "has just begun, centers have been opened, the vaccine has been delivered, and in the near future it will be administered to the first volunteers, until the start of the study."
He said that the third phase of clinical trials will last "at least six months."
“Perhaps, if required, the observation will be increased to a year, but the volunteers will be monitored for six months,” Logunov said.
On August 31, it was reported that in Moscow, more than 3 thousand volunteers applied to participate in a post-registration study of a vaccine against coronavirus infection.
Russian Minister of Health Mikhail Murashko said that mass vaccination against coronavirus infection of people from risk groups is planned for the period after November - December 2020.
Doctor of Biological Sciences, Professor of Moscow State University named after M.V.
Lomonosov, Alexey Agranovsky, in an interview with the FAN, commented on the development of a vaccine against COVID-19 by Russian scientists.